They discovered that miR-15b-5p can downregulate the expression of PD-L1, leading to the inhibition of tumor formation and increased sensitivity to anti-PD-1 treatment in models of colitis-associated cancer (CAC) and CRC. This evidence concerns the gene PDCD1 and colorectal carcinoma.